Oroscomucoid like protein 3 (ORMDL3) transgenic mice have reduced levels of sphingolipids including sphingosine-1-phosphate and ceramide - 19/04/17
Doi : 10.1016/j.jaci.2016.08.053
Marina Miller, MD, PhD a, Peter Rosenthal, BS a, Andrew Beppu, BS a, Ruth Gordillo, PhD b, David H. Broide, MB, ChB a 
a Department of Medicine, University of California San Diego, La Jolla, Calif
b Internal Medicine, Touchstone Diabetes Center, the University of Texas Southwestern Medical Center, Dallas, Tex
| This study was supported by the National Institutes of Health (grant nos. AI 107779, AI 38425, AI 70535, AI 72115, and AI242236 to D.H.B.). |
|
| Disclosure of potential conflict of interest: D. H. Broide has received a grant from the National Institutes of Health. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 139 - N° 4
P. 1373 - avril 2017 Retour au numéro
Article précédent
- Tertiary lymphoid organs in recalcitrant chronic rhinosinusitis
- Aden Lau, Susan Lester, Sophia Moraitis, Judy Ou, Alkis J. Psaltis, Shaun McColl, Maureen Rischmueller, Peter-John Wormald, Sarah Vreugde
- Prenatal phthalate exposure associates with low regulatory T-cell numbers and atopic dermatitis in early childhood: Results from the LINA mother-child study
- Gunda Herberth, Arkadiusz Pierzchalski, Ralph Feltens, Mario Bauer, Stefan Röder, Sven Olek, Denise Hinz, Michael Borte, Martin von Bergen, Irina Lehmann, LINA Study Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?